Kaken Pharmaceutical Co (4521) Price & Analysis

Compare

0 Followers

4521 Stock Chart & Stats

Day’s Range― - ―

52-Week Range¥3,651.00 - ¥4,901.00

Previous CloseN/A

Volume130.70K

Average Volume (3M)106.07K

Market Cap

¥139.28B

Enterprise Value¥93.77B

Total Cash (Recent Filing)¥79.75B

Total Debt (Recent Filing)¥3.85B

Price to Earnings (P/E)11.7

Beta0.29

Next Earnings

Nov 06, 2025

EPS EstimateN/A

Next Dividend Ex-Date

Sep 29, 2025

Dividend Yield2.96%

Share Statistics

EPS (TTM)7.13

Shares Outstanding44,139,730

10 Day Avg. Volume108,730

30 Day Avg. Volume106,070

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥4,982.97

Price Target Upside28.39% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

4521 FAQ

What was Kaken Pharmaceutical Co ’s price range in the past 12 months?

Kaken Pharmaceutical Co lowest stock price was ¥3651.00 and its highest was ¥4901.00 in the past 12 months.

What is Kaken Pharmaceutical Co ’s market cap?

Kaken Pharmaceutical Co ’s market cap is ¥139.28B.

When is Kaken Pharmaceutical Co ’s upcoming earnings report date?

Kaken Pharmaceutical Co ’s upcoming earnings report date is Nov 06, 2025 which is in 85 days.

How were Kaken Pharmaceutical Co ’s earnings last quarter?

Kaken Pharmaceutical Co released its earnings results on Aug 07, 2025. The company reported ¥7.13 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.13.

Is Kaken Pharmaceutical Co overvalued?

According to Wall Street analysts Kaken Pharmaceutical Co ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Kaken Pharmaceutical Co pay dividends?

Kaken Pharmaceutical Co pays a Semiannually dividend of ¥95 which represents an annual dividend yield of 2.96%. See more information on Kaken Pharmaceutical Co dividends here

What is Kaken Pharmaceutical Co ’s EPS estimate?

Kaken Pharmaceutical Co ’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kaken Pharmaceutical Co have?

Kaken Pharmaceutical Co has 44,139,730 shares outstanding.

What happened to Kaken Pharmaceutical Co ’s price movement after its last earnings report?

Kaken Pharmaceutical Co reported an EPS of ¥7.13 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.07%.

Which hedge fund is a major shareholder of Kaken Pharmaceutical Co ?

Currently, no hedge funds are holding shares in JP:4521

Company Description

Kaken Pharmaceutical Co

Kaken Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that operates within the healthcare sector. It is primarily engaged in the research, development, manufacture, and sale of pharmaceuticals and medical devices. The company's core products include prescription medications, dermatological treatments, and orthopedic devices. With a strong emphasis on innovation, Kaken Pharmaceutical focuses on providing solutions for unmet medical needs, particularly in areas like dermatology, orthopedics, and immunology.

Kaken Pharmaceutical Co (4521) Earnings & Revenues

Historic Earnings Reports

4521 Stock 12 Month Forecast

Average Price Target

¥4,982.97

▲(28.39% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3790":"¥3,790","5601":"¥5,601","4242.75":"¥4,242.8","4695.5":"¥4,695.5","5148.25":"¥5,148.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5600.4738635596,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥5.60K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4982.970531697,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥4.98K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4365.4671998344,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥4.37K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3790,4242.75,4695.5,5148.25,5601],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2021","6":"May<br/>2021","9":"Dec<br/>2024","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3791,3930.1902971968925,4069.3805943937846,4208.570891590677,4347.761188787569,4486.951485984462,4626.141783181354,4765.332080378246,4904.522377575138,5043.712674772031,5182.902971968923,5322.093269165816,5461.283566362708,{"y":5600.4738635596,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3791,3882.6900408997694,3974.3800817995384,4066.070122699308,4157.760163599077,4249.450204498847,4341.140245398616,4432.830286298385,4524.520327198154,4616.2103680979235,4707.9004089976925,4799.590449897461,4891.280490797231,{"y":4982.970531697,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3791,3835.1897846026463,3879.3795692052922,3923.5693538079386,3967.7591384105845,4011.948923013231,4056.138707615877,4100.328492218523,4144.518276821169,4188.708061423816,4232.897846026462,4277.0876306291075,4321.277415231754,{"y":4365.4671998344,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3792.08,"date":1604188800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3792.08,"date":1606780800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3792.08,"date":1609459200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3792.08,"date":1612137600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3792.08,"date":1614556800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3792.08,"date":1617235200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3826.09,"date":1619827200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3826.09,"date":1619827200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3948.823,"date":1635724800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4246.43,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4489,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4041,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3791,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >